Design, synthesis, and biological evaluation of novel trifluoromethyl-substituted quinolinone derivatives targeting triple-negative breast cancer
Molecular Diversity · 20.08.2026 · 30 (6) · 10703-10716
DOI: 10.1007/s11030-026-11701-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, online erschienen am 20.08.2026. Verfasst von Mei Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, School of Pharmacy, Zunyi Medical University, Zunyi, 563000, G…. Hauptthemen laut MEDLINE: Quinolones, Triple Negative Breast Neoplasms, Antineoplastic Agents, Drug Design. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Guizhou Provincial Basic Research Program, National Natural Science Foundation of China, Zunyi Medical University.
Abstract (Originalsprache)
To develop more effective chemotherapeutic agents capable of simultaneously suppressing the growth and metastasis of triple-negative breast cancer (TNBC), a series of novel trifluoromethyl-substituted quinolinone derivatives were synthesized via a visible-light-promoted coupling reaction between coumarin/quinolinone precursors and α-trifluoromethylalkyl bromides. All newly synthesized compounds were fully characterized by 1H NMR, 13C NMR, 19F NMR and high-resolution mass spectrometry. The lead candidate (3a) was obtained, which exhibited potent cytotoxicity to TNBC cell line MDA-MB-231. Furthermore, 3a potently suppressed colony formation and three-dimensional spheroid growth, while markedly inhibited MDA-MB-231 migratory and invasive capacities. Notably, 3a exhibited superior antitumor and anti-metastatic activity in vivo than Paclitaxel. Mechanistic studies revealed that 3a induced apoptosis by regulating the BCL-2/Caspase-3 pathway and suppressed metastasis through downregulating the expression of VEGFR-2, MMP-2, and MMP-9.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, School of Pharmacy, Zunyi Medical University, Zunyi, 563000, Guizhou, China.
- School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua, 418000, Hunan, China. xueyu_man@foxmail.com.
- Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, School of Pharmacy, Zunyi Medical University, Zunyi, 563000, Guizhou, China. hechy2002@163.com.
Förderung
- Guizhou Provincial Basic Research Program
- National Natural Science Foundation of China
- Zunyi Medical University
- Education Department of Guizhou Province
Zitieren
APA
Zhang, M., Chen, M., Yang, Y., Qiao, S., Yao, Q., Jia, J., Man, X., & He, C. Y. (2026). Design, synthesis, and biological evaluation of novel trifluoromethyl-substituted quinolinone derivatives targeting triple-negative breast cancer. Molecular Diversity, 30(6), 10703-10716. https://doi.org/10.1007/s11030-026-11701-4
Vancouver
Zhang M, Chen M, Yang Y, Qiao S, Yao Q, Jia J, et al. Design, synthesis, and biological evaluation of novel trifluoromethyl-substituted quinolinone derivatives targeting triple-negative breast cancer. Molecular Diversity. 2026;30(6):10703-10716. doi:10.1007/s11030-026-11701-4
BibTeX
@article{Zhang2026,
author = {Zhang, Mei and Chen, Man and Yang, Yimin and Qiao, Sirui and Yao, Qiuli and Jia, Jia and Man, Xueyu and He, Chun-Yang},
title = {Design, synthesis, and biological evaluation of novel trifluoromethyl-substituted quinolinone derivatives targeting triple-negative breast cancer},
journal = {Molecular Diversity},
year = {2026},
volume = {30},
number = {6},
pages = {10703--10716},
doi = {10.1007/s11030-026-11701-4}
}
EUVIMED